Should we loosen the grip on drug companies?

AUTOR(ES)

Smith, Richard

FONTE

BMJ Publishing Group Ltd.

RESUMO

It costs $40bn a year to produce just a handful of new drugs. Richard Smith reviews a highly publicised new book that claims over-regulation is holding the drug industry back.

Documentos Relacionados

• Should patient groups accept money from drug companies? No
• Should patient groups accept money from drug companies? Yes
• A bad week for drug companies?
• Should drug companies be allowed to sponsor Cochrane reviews?
• What should we call the 'crista'?